RHYTHM BIOSCIENCES LIMITED — Capital/Financing Update 2021

Sep 12, 2021

ASX Announcement

==> picture [211 x 73] intentionally omitted <==

ASX code: RHY

ACN: 619 459 335

13 September 2021

NOTICE UNDER SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001

• (a) The Company has issued 1,500,000 full ordinary paid shares (Shares) at an issue price of $0.85 (85 cents) per Share per ASX Listing Rule 7.1.

• (b) The Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act.

• (c) As at the date of this notice, the Company has complied with:

  • the provisions of Chapter 2M of the Corporations Act, as they apply to the Company; and

  • section 674 of the Corporation Act.

• (d) As at the date of this notice, there is no 'excluded information' (within the meaning of sections 708A(7) and 708A(8) of the Corporations Act) required to be disclosed under section 708A(6)(e) of the Corporations Act.

Released with authority of the Board.

==> picture [92 x 51] intentionally omitted <==

Adrien Wing Company Secretary

Directors

Australian Registered Office Level 2, 480 Collins Street Melbourne VIC 3000 www.rhythmbio.com

Rhythm Biosciences ACN: 619 459 335 ASX: RHY

Issued Capital 207,300,081 Shares 16,848,616 Options

Otto Buttula – Chairman of the Board Trevor John Lockett – Executive Director Louis James Panaccio – Non-Executive Director Eduardo Vom – Non-Executive Director